Covaxin trials on children begin at AIIMS-Patna
The All India Institute of Medical Sciences (AIIMS) in Patna has begun paediatric trials for the Covid-19 vaccine produced by Bharat Biotech, Covaxin. According to the reports, the names of 15 children were registered for the clinical trials. After conducting all the required tests, the health officials have administered 0.5ml of the vaccine to three children by intramuscular means and observed them for two hours. The doctors have concluded that the first vaccine trial has not posed any threat to them.
AIIMS is likely to conduct clinical trials on 100 children to arrive at the conclusion. So far, the names of 108 children were registered. After screening them, the doctors will administer the vaccine to them. India is likely to gear up for the vaccination process on children after two to three successful trials.